The study reveals that pomegranate juice does not significantly affect vascular adhesion factors, but can effectively reduce the inflammatory marker, interleukin-6.
In order to evaluate the role of pomegranate in endothelial dysfunction, databases including PubMed, Scopus, Web of Science, Cochrane, and Google Scholar were utilized up until July 2020. Relevant studies were chosen that examined pomegranate's impacts on vascular adhesion factors, namely intercellular adhesion molecule 1, vascular cell adhesion molecule 1, E-selectin, and interleukin-6. Computational tools were used to analyse this large data set.
The results demonstrated that human studies showed no significant effects of pomegranate juice on intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin compared to the control group. However, results revealed that pomegranate juice could significantly lower interleukin-6. Despite the absence of significant impacts on vascular adhesion factors, the notable reduction of interleukin-6 suggests the potential of pomegranate juice in treating endothelial dysfunction-related conditions such as cardiovascular diseases.
